OncoBeta GmbH

The multi-centre prospective study will evaluate the efficacy of the Rhenium-SCT® in non-melanoma skin cancer patients

Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia

Province of Gauteng South Africa is first to offer an innovative single session keloid treatment without need of surgery

Garching - OncoBeta® GmbH and their subsidiary OncoBeta Therapeutics Pty Ltd.

Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer to be produced in Australia

Grupo RPH is now the Official Rhenium-SCT® Sales Representative and Distributor in Brazil for the treatment of Non-Melanoma Skin Cancer.

The first Rhenium-SCT® treatment was accomplished by the interregional professional association for nuclear medicine in Hanau

New recognition of OncoBeta's success in developing and providing an innovative therapy for non-melanoma skin cancer patients.

The interregional professional association for nuclear medicine in Hanau is the first treatment center in Germany offering Rhenium-SCT® for the treatment of non-melanoma skin cancer

Recognition for OncoBeta`s mission to give non-melanocytic skin cancer patients back their quality of life.